A Policy Prescription for Reducing Health Disparities—Achieving Pharmacoequity

In 2019, the US spent $3.8 trillion on health care, including an estimated $370 billion on retail prescription drugs alone. On average, individuals in the US spend more than $1100 per capita annually out of pocket on health care, but this spending is inequitably distributed. Specifically, racial and...

Full description

Saved in:
Bibliographic Details
Published inJAMA : the journal of the American Medical Association Vol. 326; no. 18; pp. 1793 - 1794
Main Authors Essien, Utibe R, Dusetzina, Stacie B, Gellad, Walid F
Format Journal Article
LanguageEnglish
Published United States American Medical Association 09.11.2021
Subjects
Chronic illnesses
Health care
Health Care Costs
Health disparities
Health Policy
Health Services Accessibility - economics
Healthcare Disparities
Humans
Insurance
Insurance, Pharmaceutical Services
Minority & ethnic groups
Prescription drugs
Prescription Drugs - economics
United States
United States
United States > US
Online AccessGet full text

Cover

More Information
Summary:In 2019, the US spent $3.8 trillion on health care, including an estimated $370 billion on retail prescription drugs alone. On average, individuals in the US spend more than $1100 per capita annually out of pocket on health care, but this spending is inequitably distributed. Specifically, racial and ethnic minority populations, who disproportionately experience higher prevalence and greater severity of chronic diseases, are more likely to not have sufficient insurance or lack insurance completely. As a result, Black individuals and Hispanic individuals often report the highest rates of cost-related delays in care and lower access to high-quality medication therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2021.17764